View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
May 16, 2011

NeuroStar TMS Therapy Effective Against Major Depressive Disorder

NeuroStar transcranial magnetic stimulation (TMS) therapy has showed effective outcome and adherence rates in patients with major depressive disorder. The open-label study, conducted at 40 clinical practices in the US, enrolled 99 patients with the condition. Pateients experie

By cms admin

NeuroStar transcranial magnetic stimulation (TMS) therapy has showed effective outcome and adherence rates in patients with major depressive disorder.

The open-label study, conducted at 40 clinical practices in the US, enrolled 99 patients with the condition.

Pateients experienced an improvement in symptoms, complete symptom resolution and average reduction in their depression symptom score.

TMS Center of New England medical director Karl Lanocha said the data provides evidence that TMS therapy has a positive impact on patients with major depression.

NeuroStar TMS Therapy is a non-systemic and non-invasive form of neuromodulation.

It stimulates nerve cells in an area of the brain that has been linked to depression by delivering highly focused MRI-strength magnetic field pulses.

The adverse affects related to treatment were scalp pain or discomfort and risk of seizures.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management